Ichiro Hanamura

6.0k citations
74 papers · 2.8k · 1 hit paper · h-index 21

Impact in

  • Hematology top 0.5%
    • Multiple Myeloma Research and Treatments
  • Oncology top 5%
    • Peptidase Inhibition and Analysis

Papers in

    • Multiple Myeloma Research and Treatments 33
    • Protein Degradation and Inhibitors 15
    • Glycosylation and Glycoproteins Research 8
    • Ubiquitin and proteasome pathways 4

Ichiro Hanamura

68 papers receiving 2.8k citations

Ichiro Hanamura's Hit Papers

The molecular classification of multiple myeloma 2006 · 789 citations
7890+6+13Years since publication250500750

Peers

Ichiro Hanamura
Comparison fields: 5 of 99
  • Hematology 1.6k
  • Oncology 807
  • Molecular Biology 1.8k
  • Genetics 252
  • Cancer Research 346
Replace Fumihiko Hayakawa with:
Fumihiko Hayakawa Japan
Yazan Alsayed United States
Kensuke Kojima Japan
Florence Magrangeas France
Katia Todoerti Italy
Claudia Scholl Germany
Artur Słupianek United States
Luca Agnelli Italy
Renate Burger Germany
Amanda L. Christie United States
Ichiro Hanamura relative to Fumihiko Hayakawa Japan Fumihiko Hayakawa's profile →
Citations per field
00.5×1.6×
Fumihiko Hayakawa · 1×
Citations per year

Countries citing papers authored by Ichiro Hanamura

Since Specialization
Citations

This map shows the geographic impact of Ichiro Hanamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ichiro Hanamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ichiro Hanamura more than expected).

Fields of papers citing papers by Ichiro Hanamura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ichiro Hanamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ichiro Hanamura. The network helps show where Ichiro Hanamura may publish in the future.

Co-authors

The 25 scholars most cited alongside Ichiro Hanamura, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ichiro Hanamura Line = papers co-authored together Ichiro Hanamura links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The molecular classification of multiple myeloma
Hit paper breakdown →
2006789
2 2006340
3 2006289
4 2000151
5 2011130
6 2010104
7 2003101
8 201283
9 200172
10 202268
11 201458
12 200557
13 202155
14 201451
15 201941
16 201332
17 202129
18 201927
19 200326
20 200624

About Ichiro Hanamura

Ichiro Hanamura is a scholar working on Hematology, Molecular Biology, Oncology, Pathology and Forensic Medicine and Genetics, having authored 74 papers that have together received 2.8k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (33 papers), Protein Degradation and Inhibitors (15 papers), Glycosylation and Glycoproteins Research (8 papers), Peptidase Inhibition and Analysis (8 papers), Immune Cell Function and Interaction (5 papers), Lymphoma Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Ubiquitin and proteasome pathways (4 papers). The work is most often cited by research in Hematology (1.6k citations), Oncology (807 citations), Molecular Biology (1.8k citations), Genetics (252 citations) and Cancer Research (346 citations). Ichiro Hanamura has collaborated with scholars based in Japan, United States and Hong Kong. Frequent co-authors include Bart Barlogie, John D. Shaughnessy, Fenghuang Zhan, Yongsheng Huang, Peter Stewart, John Crowley, Frits van Rhee, Bart Burington, Jeffrey R. Sawyer and Guido Tricot. Their work appears in journals such as Blood, International Journal of Hematology, Cancer Science, International Journal of Molecular Sciences and Cell Death Discovery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact